| | SLO | ENG | Piškotki in zasebnost

Večja pisava | Manjša pisava

Izpis gradiva Pomoč

Naslov:Vaccines immunize people; legislation immunizes vaccine manufacturers. Legislation in the United States Regulating liability for the manufacture, distribution and administration of vaccines
Avtorji:ID Heller, Thomas Allan (Avtor)
Datoteke:.pdf Heller-2021-VACCINES_IMMUNIZE_PEOPLE;_LEGISLAT.pdf (653,52 KB)
MD5: 4FF20F56967AC01E7E17E78A68B97848
 
URL https://doi.org/10.18690/mls.14.1.1-42.2021
 
Jezik:Angleški jezik
Vrsta gradiva:Znanstveno delo
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:PF - Pravna fakulteta
UZUM - Univerzitetna založba Univerze v Mariboru
Opis:Infectious diseases have caused widespread misery, and have wreaked havoc physically, mentally, economically, politically, and socially. Fortunately, in more recent years, scientists have developed vaccines. Vaccines are generally very safe, but cause side effects in a small percentage of cases. The United States Congress has passed two major pieces of legislation that provide sweeping tort immunity to vaccine manufacturers and others. In 1986 Congress passed the National Childhood Vaccine Injury Act (NCVIA) and in 2005 it passed the Public Readiness and Emergency Preparedness Act (PREP ACT). Both Acts were passed to encourage manufacturers to develop vaccines, particularly in times of public emergencies, in exchange for expansive liability protection. Both Acts established no-fault type compensation schemes to compensate those suffering injury or death from vaccines without having to resort to typical litigation. The author discusses both Acts in detail, in the context of the current Covid-19 crisis.
Ključne besede:vaccines, pandemics, Public Readiness and Emergency Preparedness Act, immunity from liability, National Childhood Vaccine Injury Act
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum sprejetja članka:20.03.2021
Datum objave:23.04.2021
Založnik:Pravna fakulteta, Pravna fakulteta, University of Maribor Press
Leto izida:2021
Št. strani:Str. 1-41
Številčenje:Letn. 14, Št. 1
PID:20.500.12556/DKUM-89918 Novo okno
UDK:351.774.7:615.371(73)
COBISS.SI-ID:66939907 Novo okno
DOI:10.18690/mls.14.1.1-42.2021 Novo okno
ISSN pri članku:2463-7955
Datum objave v DKUM:19.08.2024
Število ogledov:211
Število prenosov:17
Metapodatki:XML DC-XML DC-RDF
Področja:Ostalo
:
Kopiraj citat
  
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
Objavi na:Bookmark and Share



Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Medicine, law & society
Založnik:Pravna fakulteta, Pravna fakulteta, University of Maribor Press
ISSN:2463-7955
COBISS.SI-ID:281851136 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:23.04.2021

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:cepiva, pandemije, nalezljive bolezni, zakonodaja, Združene države Amerike


Zbirka

To gradivo je del naslednjih zbirk del:
  1. Medicine, law & society

Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici